September 16, 2013

There has been a lot of wailing amongst multinational pharma companies about India’s uniquely unfriendly attitude to patents. Now, it might be starting to look like the new normal. The MNC’s are worried about three separate developments in India that they think will reduce incentives for innovation Compulsory licences where a local manufacturer is allowed …

India’s patent system on meds may be the new normal #accesstomedicine #patent Read More »

In a recently published article published in the Hindu , it was reported that since 2012 there has been a significant decrease in abortion drugs. Quoting a survey survey done in Maharashtra by the Indian chapter of Ipas, an international non-profit organisation working for safe abortions, the drugs Mifepristone and misoprostol were available in only 10 …

Study: Shortage of drugs hit abortion services nation wide Read More »